Product Description: Peresolimab is a humanized IgG1-κ antibody targeting to PD-1. Peresolimab potentially stimulates physiological immune inhibitory pathways to restore immune homeostasis[1][2].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Tuttle J, et al. Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis. Reply. N Engl J Med. 2023 Jul 27;389(4):378-379./[2]Peresolimab. IMGT/mAb-DB.